Biologics Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Size Analysis

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Biologics
  1. By Value
  2. Monoclonal antibodies
    1. Monoclonal antibodies By Value
  3. Recombinant proteins & enzymes
    1. Recombinant proteins & enzymes By Value
  4. Vaccines
    1. Vaccines By Value
  5. Cell & Gene Therapies
    1. Cell & Gene Therapies By Value
  6. Nucleic acid Therapeutics
    1. Nucleic acid Therapeutics By Value
  7. Other Products
    1. Other Products By Value
3. Biosimilar
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Development Services
  1. By Value
  2. Cell Line Development
    1. Cell Line Development By Value
  3. Process Development
    1. Process Development By Value
    2. Upstream
      1. Upstream By Value
    3. Downstream
      1. Downstream By Value
  4. Analytical Testing & Method Validation
    1. Analytical Testing & Method Validation By Value
  5. Other Services
    1. Other Services By Value
3. GMP Manufacturing
  1. By Value
  2. API Manufacturing
    1. API Manufacturing By Value
  3. Finished Drug Products Manufacturing
    1. Finished Drug Products Manufacturing By Value
4. Fill-Finish & Packaging
  1. By Value
5. Other Services
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Clinical
  1. By Value
3. Commercial
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Mammalian
  1. By Value
3. Microbial
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Other End User
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biologics
  1. By Value
  2. Monoclonal antibodies
    1. Monoclonal antibodies By Value
  3. Recombinant proteins & enzymes
    1. Recombinant proteins & enzymes By Value
  4. Vaccines
    1. Vaccines By Value
  5. Cell & Gene Therapies
    1. Cell & Gene Therapies By Value
  6. Nucleic acid Therapeutics
    1. Nucleic acid Therapeutics By Value
  7. Other Products
    1. Other Products By Value
3. Biosimilar
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Development Services
  1. By Value
  2. Cell Line Development
    1. Cell Line Development By Value
  3. Process Development
    1. Process Development By Value
    2. Upstream
      1. Upstream By Value
    3. Downstream
      1. Downstream By Value
  4. Analytical Testing & Method Validation
    1. Analytical Testing & Method Validation By Value
  5. Other Services
    1. Other Services By Value
3. GMP Manufacturing
  1. By Value
  2. API Manufacturing
    1. API Manufacturing By Value
  3. Finished Drug Products Manufacturing
    1. Finished Drug Products Manufacturing By Value
4. Fill-Finish & Packaging
  1. By Value
5. Other Services
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Clinical
  1. By Value
3. Commercial
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Mammalian
  1. By Value
3. Microbial
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Other End User
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Biologics
    1. By Value
    2. Monoclonal antibodies
      1. Monoclonal antibodies By Value
    3. Recombinant proteins & enzymes
      1. Recombinant proteins & enzymes By Value
    4. Vaccines
      1. Vaccines By Value
    5. Cell & Gene Therapies
      1. Cell & Gene Therapies By Value
    6. Nucleic acid Therapeutics
      1. Nucleic acid Therapeutics By Value
    7. Other Products
      1. Other Products By Value
  3. Biosimilar
    1. By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Development Services
    1. By Value
    2. Cell Line Development
      1. Cell Line Development By Value
    3. Process Development
      1. Process Development By Value
      2. Upstream
        
        Upstream By Value
      3. Downstream
        
        Downstream By Value
    4. Analytical Testing & Method Validation
      1. Analytical Testing & Method Validation By Value
    5. Other Services
      1. Other Services By Value
  3. GMP Manufacturing
    1. By Value
    2. API Manufacturing
      1. API Manufacturing By Value
    3. Finished Drug Products Manufacturing
      1. Finished Drug Products Manufacturing By Value
  4. Fill-Finish & Packaging
    1. By Value
  5. Other Services
    1. By Value
3. By Scale
  1. Introduction
    1. Scale By Value
  2. Clinical
    1. By Value
  3. Commercial
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. Mammalian
    1. By Value
  3. Microbial
    1. By Value
5. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Other End User
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biologics
  1. By Value
  2. Monoclonal antibodies
    1. Monoclonal antibodies By Value
  3. Recombinant proteins & enzymes
    1. Recombinant proteins & enzymes By Value
  4. Vaccines
    1. Vaccines By Value
  5. Cell & Gene Therapies
    1. Cell & Gene Therapies By Value
  6. Nucleic acid Therapeutics
    1. Nucleic acid Therapeutics By Value
  7. Other Products
    1. Other Products By Value
3. Biosimilar
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Development Services
  1. By Value
  2. Cell Line Development
    1. Cell Line Development By Value
  3. Process Development
    1. Process Development By Value
    2. Upstream
      1. Upstream By Value
    3. Downstream
      1. Downstream By Value
  4. Analytical Testing & Method Validation
    1. Analytical Testing & Method Validation By Value
  5. Other Services
    1. Other Services By Value
3. GMP Manufacturing
  1. By Value
  2. API Manufacturing
    1. API Manufacturing By Value
  3. Finished Drug Products Manufacturing
    1. Finished Drug Products Manufacturing By Value
4. Fill-Finish & Packaging
  1. By Value
5. Other Services
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Clinical
  1. By Value
3. Commercial
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Mammalian
  1. By Value
3. Microbial
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Other End User
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Biologics
    1. By Value
    2. Monoclonal antibodies
      1. Monoclonal antibodies By Value
    3. Recombinant proteins & enzymes
      1. Recombinant proteins & enzymes By Value
    4. Vaccines
      1. Vaccines By Value
    5. Cell & Gene Therapies
      1. Cell & Gene Therapies By Value
    6. Nucleic acid Therapeutics
      1. Nucleic acid Therapeutics By Value
    7. Other Products
      1. Other Products By Value
  3. Biosimilar
    1. By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Development Services
    1. By Value
    2. Cell Line Development
      1. Cell Line Development By Value
    3. Process Development
      1. Process Development By Value
      2. Upstream
        
        Upstream By Value
      3. Downstream
        
        Downstream By Value
    4. Analytical Testing & Method Validation
      1. Analytical Testing & Method Validation By Value
    5. Other Services
      1. Other Services By Value
  3. GMP Manufacturing
    1. By Value
    2. API Manufacturing
      1. API Manufacturing By Value
    3. Finished Drug Products Manufacturing
      1. Finished Drug Products Manufacturing By Value
  4. Fill-Finish & Packaging
    1. By Value
  5. Other Services
    1. By Value
3. By Scale
  1. Introduction
    1. Scale By Value
  2. Clinical
    1. By Value
  3. Commercial
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. Mammalian
    1. By Value
  3. Microbial
    1. By Value
5. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Other End User
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biologics
  1. By Value
  2. Monoclonal antibodies
    1. Monoclonal antibodies By Value
  3. Recombinant proteins & enzymes
    1. Recombinant proteins & enzymes By Value
  4. Vaccines
    1. Vaccines By Value
  5. Cell & Gene Therapies
    1. Cell & Gene Therapies By Value
  6. Nucleic acid Therapeutics
    1. Nucleic acid Therapeutics By Value
  7. Other Products
    1. Other Products By Value
3. Biosimilar
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Development Services
  1. By Value
  2. Cell Line Development
    1. Cell Line Development By Value
  3. Process Development
    1. Process Development By Value
    2. Upstream
      1. Upstream By Value
    3. Downstream
      1. Downstream By Value
  4. Analytical Testing & Method Validation
    1. Analytical Testing & Method Validation By Value
  5. Other Services
    1. Other Services By Value
3. GMP Manufacturing
  1. By Value
  2. API Manufacturing
    1. API Manufacturing By Value
  3. Finished Drug Products Manufacturing
    1. Finished Drug Products Manufacturing By Value
4. Fill-Finish & Packaging
  1. By Value
5. Other Services
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Clinical
  1. By Value
3. Commercial
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Mammalian
  1. By Value
3. Microbial
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Other End User
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Biologics
    1. By Value
    2. Monoclonal antibodies
      1. Monoclonal antibodies By Value
    3. Recombinant proteins & enzymes
      1. Recombinant proteins & enzymes By Value
    4. Vaccines
      1. Vaccines By Value
    5. Cell & Gene Therapies
      1. Cell & Gene Therapies By Value
    6. Nucleic acid Therapeutics
      1. Nucleic acid Therapeutics By Value
    7. Other Products
      1. Other Products By Value
  3. Biosimilar
    1. By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Development Services
    1. By Value
    2. Cell Line Development
      1. Cell Line Development By Value
    3. Process Development
      1. Process Development By Value
      2. Upstream
        
        Upstream By Value
      3. Downstream
        
        Downstream By Value
    4. Analytical Testing & Method Validation
      1. Analytical Testing & Method Validation By Value
    5. Other Services
      1. Other Services By Value
  3. GMP Manufacturing
    1. By Value
    2. API Manufacturing
      1. API Manufacturing By Value
    3. Finished Drug Products Manufacturing
      1. Finished Drug Products Manufacturing By Value
  4. Fill-Finish & Packaging
    1. By Value
  5. Other Services
    1. By Value
3. By Scale
  1. Introduction
    1. Scale By Value
  2. Clinical
    1. By Value
  3. Commercial
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. Mammalian
    1. By Value
  3. Microbial
    1. By Value
5. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Other End User
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biologics
  1. By Value
  2. Monoclonal antibodies
    1. Monoclonal antibodies By Value
  3. Recombinant proteins & enzymes
    1. Recombinant proteins & enzymes By Value
  4. Vaccines
    1. Vaccines By Value
  5. Cell & Gene Therapies
    1. Cell & Gene Therapies By Value
  6. Nucleic acid Therapeutics
    1. Nucleic acid Therapeutics By Value
  7. Other Products
    1. Other Products By Value
3. Biosimilar
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Development Services
  1. By Value
  2. Cell Line Development
    1. Cell Line Development By Value
  3. Process Development
    1. Process Development By Value
    2. Upstream
      1. Upstream By Value
    3. Downstream
      1. Downstream By Value
  4. Analytical Testing & Method Validation
    1. Analytical Testing & Method Validation By Value
  5. Other Services
    1. Other Services By Value
3. GMP Manufacturing
  1. By Value
  2. API Manufacturing
    1. API Manufacturing By Value
  3. Finished Drug Products Manufacturing
    1. Finished Drug Products Manufacturing By Value
4. Fill-Finish & Packaging
  1. By Value
5. Other Services
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Clinical
  1. By Value
3. Commercial
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Mammalian
  1. By Value
3. Microbial
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Other End User
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Biologics
    1. By Value
    2. Monoclonal antibodies
      1. Monoclonal antibodies By Value
    3. Recombinant proteins & enzymes
      1. Recombinant proteins & enzymes By Value
    4. Vaccines
      1. Vaccines By Value
    5. Cell & Gene Therapies
      1. Cell & Gene Therapies By Value
    6. Nucleic acid Therapeutics
      1. Nucleic acid Therapeutics By Value
    7. Other Products
      1. Other Products By Value
  3. Biosimilar
    1. By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Development Services
    1. By Value
    2. Cell Line Development
      1. Cell Line Development By Value
    3. Process Development
      1. Process Development By Value
      2. Upstream
        
        Upstream By Value
      3. Downstream
        
        Downstream By Value
    4. Analytical Testing & Method Validation
      1. Analytical Testing & Method Validation By Value
    5. Other Services
      1. Other Services By Value
  3. GMP Manufacturing
    1. By Value
    2. API Manufacturing
      1. API Manufacturing By Value
    3. Finished Drug Products Manufacturing
      1. Finished Drug Products Manufacturing By Value
  4. Fill-Finish & Packaging
    1. By Value
  5. Other Services
    1. By Value
3. By Scale
  1. Introduction
    1. Scale By Value
  2. Clinical
    1. By Value
  3. Commercial
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. Mammalian
    1. By Value
  3. Microbial
    1. By Value
5. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Other End User
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Biologics
  1. By Value
  2. Monoclonal antibodies
    1. Monoclonal antibodies By Value
  3. Recombinant proteins & enzymes
    1. Recombinant proteins & enzymes By Value
  4. Vaccines
    1. Vaccines By Value
  5. Cell & Gene Therapies
    1. Cell & Gene Therapies By Value
  6. Nucleic acid Therapeutics
    1. Nucleic acid Therapeutics By Value
  7. Other Products
    1. Other Products By Value
3. Biosimilar
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Development Services
  1. By Value
  2. Cell Line Development
    1. Cell Line Development By Value
  3. Process Development
    1. Process Development By Value
    2. Upstream
      1. Upstream By Value
    3. Downstream
      1. Downstream By Value
  4. Analytical Testing & Method Validation
    1. Analytical Testing & Method Validation By Value
  5. Other Services
    1. Other Services By Value
3. GMP Manufacturing
  1. By Value
  2. API Manufacturing
    1. API Manufacturing By Value
  3. Finished Drug Products Manufacturing
    1. Finished Drug Products Manufacturing By Value
4. Fill-Finish & Packaging
  1. By Value
5. Other Services
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Clinical
  1. By Value
3. Commercial
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. Mammalian
  1. By Value
3. Microbial
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnology Companies
  1. By Value
3. Academic & Research Institutes
  1. By Value
4. Other End User
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Biologics
    1. By Value
    2. Monoclonal antibodies
      1. Monoclonal antibodies By Value
    3. Recombinant proteins & enzymes
      1. Recombinant proteins & enzymes By Value
    4. Vaccines
      1. Vaccines By Value
    5. Cell & Gene Therapies
      1. Cell & Gene Therapies By Value
    6. Nucleic acid Therapeutics
      1. Nucleic acid Therapeutics By Value
    7. Other Products
      1. Other Products By Value
  3. Biosimilar
    1. By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Development Services
    1. By Value
    2. Cell Line Development
      1. Cell Line Development By Value
    3. Process Development
      1. Process Development By Value
      2. Upstream
        
        Upstream By Value
      3. Downstream
        
        Downstream By Value
    4. Analytical Testing & Method Validation
      1. Analytical Testing & Method Validation By Value
    5. Other Services
      1. Other Services By Value
  3. GMP Manufacturing
    1. By Value
    2. API Manufacturing
      1. API Manufacturing By Value
    3. Finished Drug Products Manufacturing
      1. Finished Drug Products Manufacturing By Value
  4. Fill-Finish & Packaging
    1. By Value
  5. Other Services
    1. By Value
3. By Scale
  1. Introduction
    1. Scale By Value
  2. Clinical
    1. By Value
  3. Commercial
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. Mammalian
    1. By Value
  3. Microbial
    1. By Value
5. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnology Companies
    1. By Value
  3. Academic & Research Institutes
    1. By Value
  4. Other End User
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Biologics Contract Development and Manufacturing Organization (CDMO) Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Lonza Group
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Samsung Biologics
WuXi Biologics
Thermo Fisher Scientific Inc.
Catalent Pharma Solutions
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim BioXcellence
AGC Biologics
Charles River Laboratories
Rentschler Biopharma SE
Siegfried Holding
Vetter Pharma International
GenScript Biologics
Recipharm
Jubilant Pharmova
Fareva
Almac Group
Sandoz Group
Biocon Biologics
Syngene International

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Dhanashri B

Senior Research Associate